240550 — DongBang Medical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual income statement for DongBang Medical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Revenue
Total Revenue	81,408	90,875	105,114	113,537
Cost of Revenue
Gross Profit	22,772	30,984	34,212	40,250
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	73,285	74,352	91,033	96,368
Operating Profit	8,122	16,523	14,081	17,169
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,619	12,505	6,791	14,283
Provision for Income Taxes
Net Income After Taxes	3,320	9,734	3,127	11,442
Minority Interest
Net Income Before Extraordinary Items
Net Income	3,192	9,775	2,914	11,703
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,192	9,775	2,914	11,703
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	98.4	477	119	550
Dividends per Share